HEADER HYDROLASE/HYDROLASE INHIBITOR 08-FEB-16 5I2E TITLE HUMAN HISTIDINE TRIAD NUCLEOTIDE BINDING PROTEIN 1 (HINT1) WITH BOUND TITLE 2 SULFAMATE INHIBITOR 3A:3-(5-O-{[3-(1H-INDOL-3-YL) TITLE 3 PROPANOYL]SULFAMOYL}-BETA-D-RIBOFURANOSYL)-3H-IMIDAZO[2,1-I]PURINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ADENOSINE 5'-MONOPHOSPHORAMIDASE; COMPND 5 EC: 3.-.-.-; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HINT1, HINT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA 2 PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMCSG7 KEYWDS HINT, HISTIDINE TRIAD, HIT, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.M.STROM,B.C.FINZEL,C.R.WAGNER REVDAT 3 27-SEP-23 5I2E 1 REMARK REVDAT 2 07-SEP-16 5I2E 1 JRNL REVDAT 1 22-JUN-16 5I2E 0 JRNL AUTH R.SHAH,A.STROM,A.ZHOU,K.M.MAIZE,B.C.FINZEL,C.R.WAGNER JRNL TITL DESIGN, SYNTHESIS, AND CHARACTERIZATION OF SULFAMIDE AND JRNL TITL 2 SULFAMATE NUCLEOTIDOMIMETIC INHIBITORS OF HHINT1. JRNL REF ACS MED.CHEM.LETT. V. 7 780 2016 JRNL REFN ISSN 1948-5875 JRNL PMID 27563403 JRNL DOI 10.1021/ACSMEDCHEMLETT.6B00169 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.25 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 29224 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.199 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 1448 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.2638 - 3.4464 0.96 2786 155 0.1614 0.1765 REMARK 3 2 3.4464 - 2.7357 0.98 2802 123 0.1637 0.1779 REMARK 3 3 2.7357 - 2.3900 0.98 2803 128 0.1697 0.1920 REMARK 3 4 2.3900 - 2.1715 0.98 2769 132 0.1680 0.1967 REMARK 3 5 2.1715 - 2.0158 0.98 2770 140 0.1776 0.2210 REMARK 3 6 2.0158 - 1.8970 0.99 2801 157 0.1838 0.1942 REMARK 3 7 1.8970 - 1.8020 0.99 2765 155 0.2016 0.2446 REMARK 3 8 1.8020 - 1.7236 0.99 2750 158 0.2138 0.2495 REMARK 3 9 1.7236 - 1.6572 0.99 2791 151 0.2391 0.2444 REMARK 3 10 1.6572 - 1.6000 0.98 2739 149 0.2750 0.2928 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.140 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.300 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 1939 REMARK 3 ANGLE : 1.089 2642 REMARK 3 CHIRALITY : 0.060 283 REMARK 3 PLANARITY : 0.005 344 REMARK 3 DIHEDRAL : 11.078 1153 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5I2E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-FEB-16. REMARK 100 THE DEPOSITION ID IS D_1000216762. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-DEC-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29254 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 39.639 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.36800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3TW2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES, 35% PEG 8000, PH 6.1, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 38.38350 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.17250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 38.38350 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 23.17250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A -2 REMARK 465 ASN A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ASP A 3 REMARK 465 GLU A 4 REMARK 465 ILE A 5 REMARK 465 ALA A 6 REMARK 465 LYS A 7 REMARK 465 ALA A 8 REMARK 465 GLN A 9 REMARK 465 VAL A 10 REMARK 465 ALA A 11 REMARK 465 SER B -2 REMARK 465 ASN B -1 REMARK 465 ALA B 0 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 ASP B 3 REMARK 465 GLU B 4 REMARK 465 ILE B 5 REMARK 465 ALA B 6 REMARK 465 LYS B 7 REMARK 465 ALA B 8 REMARK 465 GLN B 9 REMARK 465 VAL B 10 REMARK 465 ALA B 11 REMARK 465 ARG B 12 REMARK 465 PRO B 13 REMARK 465 GLY B 14 REMARK 465 GLY B 15 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 12 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 67 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 67 O HOH A 301 2.01 REMARK 500 OE1 GLU B 71 O HOH B 301 2.16 REMARK 500 O SER B 107 O HOH B 302 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 35 -156.46 -133.94 REMARK 500 SER B 107 -71.89 -83.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 67D A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3TW2 RELATED DB: PDB REMARK 900 3TW2 CONTAINS THE SAME PROTEIN COMPLEXED WITH AMP IN A C2 SPACEGROUP REMARK 900 RELATED ID: 4EQE RELATED DB: PDB REMARK 900 4EQE CONTAINS THE SAME PROTEIN COMPLEXED WITH LYS-AMS IN A C2 REMARK 900 SPACEGROUP REMARK 900 RELATED ID: 4EQG RELATED DB: PDB REMARK 900 4EQG CONTAINS THE SAME PROTEIN COMPLEXED WITH ALA-AMS IN A C2 REMARK 900 SPACEGROUP REMARK 900 RELATED ID: 4EQH RELATED DB: PDB REMARK 900 4EQH CONTAINS THE SAME PROTEIN COMPLEXED WITH TRP-AMS IN A C2 REMARK 900 SPACEGROUP REMARK 900 RELATED ID: 5I2F RELATED DB: PDB DBREF 5I2E A 1 126 UNP P49773 HINT1_HUMAN 1 126 DBREF 5I2E B 1 126 UNP P49773 HINT1_HUMAN 1 126 SEQADV 5I2E SER A -2 UNP P49773 EXPRESSION TAG SEQADV 5I2E ASN A -1 UNP P49773 EXPRESSION TAG SEQADV 5I2E ALA A 0 UNP P49773 EXPRESSION TAG SEQADV 5I2E SER B -2 UNP P49773 EXPRESSION TAG SEQADV 5I2E ASN B -1 UNP P49773 EXPRESSION TAG SEQADV 5I2E ALA B 0 UNP P49773 EXPRESSION TAG SEQRES 1 A 129 SER ASN ALA MET ALA ASP GLU ILE ALA LYS ALA GLN VAL SEQRES 2 A 129 ALA ARG PRO GLY GLY ASP THR ILE PHE GLY LYS ILE ILE SEQRES 3 A 129 ARG LYS GLU ILE PRO ALA LYS ILE ILE PHE GLU ASP ASP SEQRES 4 A 129 ARG CYS LEU ALA PHE HIS ASP ILE SER PRO GLN ALA PRO SEQRES 5 A 129 THR HIS PHE LEU VAL ILE PRO LYS LYS HIS ILE SER GLN SEQRES 6 A 129 ILE SER VAL ALA GLU ASP ASP ASP GLU SER LEU LEU GLY SEQRES 7 A 129 HIS LEU MET ILE VAL GLY LYS LYS CYS ALA ALA ASP LEU SEQRES 8 A 129 GLY LEU ASN LYS GLY TYR ARG MET VAL VAL ASN GLU GLY SEQRES 9 A 129 SER ASP GLY GLY GLN SER VAL TYR HIS VAL HIS LEU HIS SEQRES 10 A 129 VAL LEU GLY GLY ARG GLN MET HIS TRP PRO PRO GLY SEQRES 1 B 129 SER ASN ALA MET ALA ASP GLU ILE ALA LYS ALA GLN VAL SEQRES 2 B 129 ALA ARG PRO GLY GLY ASP THR ILE PHE GLY LYS ILE ILE SEQRES 3 B 129 ARG LYS GLU ILE PRO ALA LYS ILE ILE PHE GLU ASP ASP SEQRES 4 B 129 ARG CYS LEU ALA PHE HIS ASP ILE SER PRO GLN ALA PRO SEQRES 5 B 129 THR HIS PHE LEU VAL ILE PRO LYS LYS HIS ILE SER GLN SEQRES 6 B 129 ILE SER VAL ALA GLU ASP ASP ASP GLU SER LEU LEU GLY SEQRES 7 B 129 HIS LEU MET ILE VAL GLY LYS LYS CYS ALA ALA ASP LEU SEQRES 8 B 129 GLY LEU ASN LYS GLY TYR ARG MET VAL VAL ASN GLU GLY SEQRES 9 B 129 SER ASP GLY GLY GLN SER VAL TYR HIS VAL HIS LEU HIS SEQRES 10 B 129 VAL LEU GLY GLY ARG GLN MET HIS TRP PRO PRO GLY HET 67D A 201 38 HET GOL B 201 6 HETNAM 67D 3-(5-O-{[3-(1H-INDOL-3-YL)PROPANOYL]SULFAMOYL}-BETA-D- HETNAM 2 67D RIBOFURANOSYL)-3H-IMIDAZO[2,1-I]PURINE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 67D C23 H23 N7 O7 S FORMUL 4 GOL C3 H8 O3 FORMUL 5 HOH *109(H2 O) HELIX 1 AA1 THR A 17 ARG A 24 1 8 HELIX 2 AA2 GLN A 62 ALA A 66 5 5 HELIX 3 AA3 GLU A 67 ASP A 69 5 3 HELIX 4 AA4 ASP A 70 LEU A 88 1 19 HELIX 5 AA5 GLY A 101 GLY A 105 1 5 HELIX 6 AA6 THR B 17 ARG B 24 1 8 HELIX 7 AA7 GLN B 62 ALA B 66 5 5 HELIX 8 AA8 GLU B 67 ASP B 69 5 3 HELIX 9 AA9 ASP B 70 LEU B 88 1 19 HELIX 10 AB1 GLY B 101 GLY B 105 1 5 SHEET 1 AA110 ILE A 31 GLU A 34 0 SHEET 2 AA110 CYS A 38 HIS A 42 -1 O ALA A 40 N ILE A 32 SHEET 3 AA110 THR A 50 PRO A 56 -1 O LEU A 53 N PHE A 41 SHEET 4 AA110 LEU A 113 GLY A 117 -1 O VAL A 115 N PHE A 52 SHEET 5 AA110 TYR A 94 GLU A 100 -1 N VAL A 97 O HIS A 114 SHEET 6 AA110 TYR B 94 GLU B 100 -1 O VAL B 98 N MET A 96 SHEET 7 AA110 LEU B 113 GLY B 117 -1 O HIS B 114 N VAL B 97 SHEET 8 AA110 THR B 50 PRO B 56 -1 N PHE B 52 O VAL B 115 SHEET 9 AA110 CYS B 38 HIS B 42 -1 N PHE B 41 O LEU B 53 SHEET 10 AA110 ILE B 31 GLU B 34 -1 N PHE B 33 O ALA B 40 CISPEP 1 TRP A 123 PRO A 124 0 0.31 CISPEP 2 TRP B 123 PRO B 124 0 5.16 SITE 1 AC1 22 PHE A 19 ILE A 22 PRO A 28 PHE A 41 SITE 2 AC1 22 HIS A 42 ASP A 43 ILE A 44 LEU A 53 SITE 3 AC1 22 ASN A 99 GLY A 105 GLN A 106 SER A 107 SITE 4 AC1 22 VAL A 108 HIS A 112 HIS A 114 HOH A 323 SITE 5 AC1 22 HOH A 325 HOH A 334 ARG B 95 MET B 121 SITE 6 AC1 22 HIS B 122 TRP B 123 SITE 1 AC2 7 TRP A 123 HOH A 330 LYS B 25 GLU B 34 SITE 2 AC2 7 LYS B 57 GLY B 105 SER B 107 CRYST1 76.767 46.345 63.932 90.00 94.73 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013026 0.000000 0.001077 0.00000 SCALE2 0.000000 0.021577 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015695 0.00000